46.46.Z - Wholesale trade of pharmaceutical and medical products
46.38.Z - Wholesale trade of other food products
46.45 - Wholesale trade of perfumes and cosmetics
47.73 - Retail sale of pharmaceutical products
47.74 - Retail sale of medical and orthopedic products
58.11 - Publishing of books
58.13 - Publishing of journals and periodicals
58.14 - Publishing activities
58.19 - Other publishing activities, excluding software publishing
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,2 | 0,5 | 0,2 | -51,3 |
EBITDA | 1,3 | 0,6 | 0,2 | -66,4 |
Short time liabilities | 2,7 | 1,6 | 1,1 | -29 |
Equity capital | 1 | 1,4 | 1,5 | 13,9 |
Operating profit (EBIT) | 1,2 | 0,6 | 0,2 | -70,1 |
Assets | 4,4 | 3,4 | 3,1 | -9,3 |
Net profit (loss) | 1 | 0,4 | 0,2 | -51,1 |
Cash | 0,2 | 0,2 | 0 | -87,7 |
Liabilities and provisions for liabilities | 3,5 | 2,1 | 1,6 | -24,2 |
Net income from sale | 13,1 | 12,8 | 12 | -6,9 |
Working assets | 4,3 | 3,3 | 3 | -8,6 |
Depreciation | 0 | 0 | 0 | 37,2 |
% | % | % | p.p. | |
Profitability of capital | 107,2 | 28,4 | 12,2 | -16,2 |
Equity capital to total assets | 21,8 | 39,2 | 49,2 | 10 |
Gross profit margin | 9,1 | 3,8 | 2 | -1,8 |
EBITDA Margin | 9,6 | 4,5 | 1,6 | -2,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 75 | 45 | 34 | -11 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane